Dolby Laboratories, Inc.
DLB
$72.38
$0.931.30%
NYSE
06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
---|---|---|---|---|---|
Net Income | 19.84% | -6.17% | 1.26% | 537.60% | 134.43% |
Total Depreciation and Amortization | 15.05% | 17.57% | 20.21% | 0.52% | -12.74% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 63.54% | -6.80% | 19.35% | -53.51% | -55.65% |
Change in Net Operating Assets | 51.25% | -6.40% | 87.32% | 121.19% | -206.38% |
Cash from Operations | 218.34% | -3.59% | 1,169.82% | 36.65% | -82.45% |
Capital Expenditure | 15.57% | 22.64% | -11.15% | 9.85% | -2.70% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 100.00% | 277.64% | -- | 2,129.74% | -103.50% |
Cash from Investing | 16.99% | 244.88% | -1,386.10% | -1,225.70% | -135.15% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 23.81% | -64.08% | 16.47% | -93.21% | -35.96% |
Repurchase of Common Stock | -13.25% | -38.81% | 58.59% | 21.35% | -35.63% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -10.21% | -10.84% | -10.49% | -10.78% | -11.07% |
Other Financing Activities | 86.47% | -- | 29.32% | -- | -- |
Cash from Financing | -4.01% | -46.90% | 53.99% | -40.47% | -58.57% |
Foreign Exchange rate Adjustments | 764.88% | 175.22% | -205.48% | 218.52% | -43.79% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 113.61% | 19.87% | 131.02% | -1,168.07% | -143.25% |